G. Liu

Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide

Dana E. Rathkopf, Matthew R. Smith, Charles J. Ryan et al. · Annals of Oncology · 2017 · 100 citations · Full text

Medicine, Oncology, Pharmacology +14

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial

Anis Hamid, Hsin-Chieh Huang, V. Wang et al. · Annals of Oncology · 2021 · 75 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Long term efficacy and QOL data of chemohormonal therapy (C-HT) in low and high volume hormone naïve metastatic prostate cancer (PrCa): E3805 CHAARTED trial

Christopher J. Sweeney, Y.-H. Chen, G. Liu et al. · Annals of Oncology · 2016 · 60 citations · Full text

Medicine, Oncology, Urology +17

Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial

Amado J. Zurita, Daniel J. George, Neal D. Shore et al. · Annals of Oncology · 2011 · 46 citations

Medicine, Oncology, Pharmacology +16

ARN-509 in Men with High Risk Non-Metastatic Castration-Resistant Prostate Cancer

Mitchell R. Smith, Emmanuel S. Antonarakis, Charles J. Ryan et al. · Annals of Oncology · 2012 · 11 citations · Full text

Medicine, Oncology, Urology +7